Kewaunee Scientific (KEQU)
(Delayed Data from NSDQ)
$34.80 USD
-0.89 (-2.48%)
Updated May 8, 2024 03:57 PM ET
After-Market: $34.62 -0.18 (-0.52%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Kewaunee Scientific Corporation falls in the month of April.
All items in Millions except Per Share data.
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 14 | 7 | 6 | 5 |
Receivables | NA | 46 | 41 | 35 | 28 |
Notes Receivable | NA | 0 | 13 | 0 | 0 |
Inventories | NA | 22 | 24 | 17 | 15 |
Other Current Assets | NA | 6 | 6 | 3 | 6 |
Total Current Assets | NA | 88 | 92 | 60 | 54 |
Net Property & Equipment | NA | 16 | 15 | 16 | 16 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 5 | 5 | 4 | 4 |
Total Assets | NA | 119 | 119 | 89 | 84 |
Liabilities & Shareholders Equity | 4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 4 | 2 | 7 | 5 |
Accounts Payable | NA | 24 | 27 | 17 | 13 |
Current Portion Long-Term Debt | NA | 1 | 1 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 6 | 8 | 6 | 5 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 4 | 4 | 3 | 3 |
Total Current Liabilities | NA | 40 | 42 | 34 | 27 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 1 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 28 | 29 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 4 | 5 | 5 | 10 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 80 | 83 | 48 | 45 |
Shareholders Equity | 4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 7 | 7 | 7 | 7 |
Capital Surplus | NA | 5 | 4 | 4 | 3 |
Retained Earnings | NA | 29 | 28 | 34 | 38 |
Other Equity | NA | -2 | -3 | -3 | -9 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 38 | 36 | 41 | 39 |
Total Liabilities & Shareholder's Equity | NA | 119 | 119 | 89 | 84 |
Total Common Equity | 0 | 38 | 36 | 41 | 39 |
Shares Outstanding | 2.80 | 2.80 | 2.70 | 2.70 | 2.70 |
Book Value Per Share | 0.00 | 13.75 | 13.40 | 15.37 | 14.33 |
Fiscal Year End for Kewaunee Scientific Corporation falls in the month of April.
All items in Millions except Per Share data.
4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 27 | 22 | 22 | 14 |
Receivables | NA | 41 | 43 | 42 | 46 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 22 | 22 | 22 | 22 |
Other Current Assets | NA | 6 | 5 | 7 | 6 |
Total Current Assets | NA | 96 | 91 | 94 | 88 |
Net Property & Equipment | NA | 17 | 18 | 17 | 16 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 5 | 5 | 5 | 5 |
Total Assets | NA | 126 | 122 | 125 | 119 |
Liabilities & Shareholders Equity | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 3 | 6 | 5 | 4 |
Accounts Payable | NA | 19 | 19 | 22 | 24 |
Current Portion Long-Term Debt | NA | 1 | 1 | 1 | 1 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 7 | 6 | 7 | 6 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 10 | 5 | 7 | 4 |
Total Current Liabilities | NA | 42 | 39 | 44 | 40 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 1 | 1 | 1 | 1 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 28 | 28 | 28 | 28 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 4 | 4 | 4 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 81 | 78 | 84 | 80 |
Shareholders Equity | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 7 | 7 | 7 | 7 |
Capital Surplus | NA | 5 | 5 | 5 | 5 |
Retained Earnings | NA | 36 | 34 | 31 | 29 |
Other Equity | NA | -3 | -3 | -2 | -2 |
Treasury Stock | NA | 1 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 45 | 43 | 41 | 38 |
Total Liabilities & Shareholder's Equity | NA | 126 | 122 | 125 | 119 |
Total Common Equity | 0 | 45 | 43 | 41 | 38 |
Shares Outstanding | 2.80 | 2.90 | 2.90 | 2.90 | 2.80 |
Book Value Per Share | 0.00 | 15.63 | 14.97 | 13.98 | 13.75 |